BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 19841089)

  • 21. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.
    Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D
    Cancer Cell; 2012 Dec; 22(6):825-37. PubMed ID: 23238017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
    Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
    J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.
    Gross O; Grupp C; Steinberg C; Zimmermann S; Strasser D; Hannesschläger N; Reindl W; Jonsson H; Huo H; Littman DR; Peschel C; Yokoyama WM; Krug A; Ruland J
    Blood; 2008 Sep; 112(6):2421-8. PubMed ID: 18192506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
    Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
    J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular architecture and regulation of BCL10-MALT1 filaments.
    Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
    Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.
    Kloo B; Nagel D; Pfeifer M; Grau M; Düwel M; Vincendeau M; Dörken B; Lenz P; Lenz G; Krappmann D
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):272-7. PubMed ID: 21173233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas.
    Eitelhuber AC; Vosyka O; Nagel D; Bognar M; Lenze D; Lammens K; Schlauderer F; Hlahla D; Hopfner KP; Lenz G; Hummel M; Verhelst SH; Krappmann D
    Chem Biol; 2015 Jan; 22(1):129-38. PubMed ID: 25556945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.
    Schimmack G; Eitelhuber AC; Vincendeau M; Demski K; Shinohara H; Kurosaki T; Krappmann D
    Cell Commun Signal; 2014 Jul; 12():49. PubMed ID: 25245034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.
    Cheng J; Maurer LM; Kang H; Lucas PC; McAllister-Lucas LM
    Cell Immunol; 2020 Sep; 355():104158. PubMed ID: 32721634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
    Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
    Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
    Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
    Front Immunol; 2018; 9():2695. PubMed ID: 30515170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling.
    Douanne T; Gavard J; Bidère N
    J Cell Sci; 2016 May; 129(9):1775-80. PubMed ID: 27006117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.
    Chan W; Schaffer TB; Pomerantz JL
    Mol Cell Biol; 2013 Jan; 33(2):429-43. PubMed ID: 23149938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.
    Baens M; Bonsignore L; Somers R; Vanderheydt C; Weeks SD; Gunnarsson J; Nilsson E; Roth RG; Thome M; Marynen P
    PLoS One; 2014; 9(8):e103774. PubMed ID: 25105596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
    Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
    Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
    Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
    EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
    Xia M; David L; Teater M; Gutierrez J; Wang X; Meydan C; Lytle A; Slack GW; Scott DW; Morin RD; Onder O; Elenitoba-Johnson KSJ; Zamponi N; Cerchietti L; Lu T; Philippar U; Fontan L; Wu H; Melnick AM
    Cancer Discov; 2022 Aug; 12(8):1922-1941. PubMed ID: 35658124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.